Cognitive and Affective Representations of Active Surveillance as a Treatment Option for Low-Risk Prostate Cancer

American Journal of Men's Health

Volumn 11, Issue 1, 2017, Pages 63-72

  Lyons, Kathleen D ^a   Li, Hsin H ^b   Mader, Emily M ^b   Stewart, Telisa M ^b   Morley, Christopher P ^b   Formica, Margaret K ^b   Perrapato, Scott D ^c   Seigne, John D ^a   Hyams, Elias S ^a   Irwin, Brian H ^c   Mosher, Terry ^a   Hegel, Mark T ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

active surveillance; choice behavior; decision making; prostatic neoplasm; qualitative research

Indexed keywords

EID: 85006493431     PISSN: 15579883     EISSN: 15579891     Source Type: Journal    
DOI: 10.1177/1557988316657041     Document Type: Article

References (26)

1. Adolfsson J., (2008). Watchful waiting and active surveillance: The current position. BJU International, 102, 10-14. doi:10.1111/j.1464-410X.2008.07585.x
2. American Cancer Society. (2015). Cancer facts and figures 2015. Atlanta, GA: Author.
3. Cooperberg M. R., Broering J. M., Kantoff P. W., Carroll P. R., (2007). Contemporary trends in low risk prostate cancer: Risk assessment and treatment. Journal of Urology, 178(3 Suppl. 1), S14-S19.
4. Cooperberg M. R., Lubeck D. P., Meng M. V., Mehta S. S., Carroll P. R., (2004). The changing face of low-risk prostate cancer: Trends in clinical presentation and primary management. Journal of Clinical Oncology, 22, 2141-2149. doi:10.1200/JCO.2004.10.062
5. Damasio A., (1994). Descartes’ error: Emotion, reason, and the human brain. New York, NY: Avon Books.
6. Diefenbach M. A., Mohamed N. E., (2007). Regret of treatment decision and its association with disease-specific quality of life following prostate cancer treatment. Cancer Investigation, 25, 449-457. doi:10.1080/07357900701359460
7. Epstein S., (1994). Integration of the cognitive and the psychodynamic unconscious. American Psychologist, 49, 709-724.
8. Filson C. P., Marks L. S., Litwin M. S., (2015). Expectant management for men with early stage prostate cancer. CA: A Cancer Journal for Clinicians, 65, 264-282. doi:10.3322/caac.21278
9. Klotz L., (2005). Active surveillance for prostate cancer: For whom? Journal of Clinical Oncology, 23, 8165-8169. doi:10.1200/jco.2005.03.3134
10. Klotz L., Zhang L., Lam A., Nam R., Mamedov A., Loblaw A., (2010). Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. Journal of Clinical Oncology, 28, 126-131. doi:10.1200/jco.2009.24.2180
11. Leventhal H., Diefenbach M., Leventhal E. A., (1992). Illness cognition: Using common sense to understand treatment adherence and affect cognition interactions. Cognitive Therapy and Research, 16, 143-163. doi:10.1007/bf01173486
12. Leventhal H., Leonard B., (1970). Findings and theory in the study of fear communications. In Berkowitz L., (Ed.), Advances in experimental social psychology (Vol. 5, pp. 119-186). New York, NY: Academic Press.
13. Litwin M. S., Pasta D. J., Yu J., Stoddard M. L., Flanders S. C., (2000). Urinary function and bother after radical prostatectomy or radiation for prostate cancer: A longitudinal, multivariate quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor. Journal of Urology, 164, 1973-1977. doi:10.1016/S0022-5347(05)66931-5
14. National Comprehensive Cancer Network. (2016). Clinical practice guidelines in oncology: Prostate cancer (Version 2). Retrieved from https://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site
15. Oliffe J. L., Davison B. J., Pickles T., Mróz L., (2009). The self-management of uncertainty among men undertaking active surveillance for low-risk prostate cancer. Qualitative Health Research, 19, 432-443. doi:10.1177/1049732309332692
16. Peters E., Diefenbach M. A., Hess T. M., Västfjäll D., (2008). Age differences in dual information-processing modes. Cancer, 113, 3556-3567. doi:10.1002/cncr.23944
17. Peters E., Lipkus I., Diefenbach M. A., (2006). The functions of affect in health communications and in the construction of health preferences. Journal of Communication, 56, S140-S162. doi:10.1111/j.1460-2466.2006.00287.x
18. Petty R. E., Wegener D. T., (1999). The elaboration likelihood model: Current status and controversies. In Trope S. C. Y., (Ed.), Dual-process theories in social psychology (pp. 37-72). New York, NY: Guilford Press.
19. Roemeling S., Roobol M. J., de Vries S. H., Wolters T., Gosselaar C., van Leenders G. J. L. H., Schröder F. H., (2007). Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: Characteristics, PSA doubling times, and outcome. European Urology, 51, 1244-1251.
20. Siegel R. L., Miller K. D., Jemal A., (2015). Cancer statistics, 2015. CA: A Cancer Journal for Clinicians, 65, 5-29. doi:10.3322/caac.21254
21. Steineck G., Helgesen F., Adolfsson J., Dickman P. W., Johansson J. E., Norlen B. J., Holmberg L., (2002). Quality of life after radical prostatectomy or watchful waiting. New England Journal of Medicine, 347, 790-796. doi:10.1056/NEJMoa021483
22. van den Bergh R. C. N., Korfage I. J., Bangma C. H. (2012). Psychological aspects of active surveillance. Current Opinion in Urology, 22, 237-242. doi:10.1097/MOU.0b013e328351dcb1
23. Wenger L. M., Oliffe J. L., (2014). Men managing cancer: A gender analysis. Sociology of Health & Illness, 36, 108-122. doi:10.1111/1467-9566.12045
24. Xu J., Dailey R. K., Eggly S., Neale A. V., Schwartz K. L., (2011). Men’s perspectives on selecting their prostate cancer treatment. Journal of the National Medical Association, 103, 468-478.
25. Xu J., Victoria Neale A., Dailey R. K., Eggly S., Schwartz K. L., (2012). Patient perspective on watchful waiting/active surveillance for localized prostate cancer. Journal of the American Board of Family Medicine, 25, 763-770. doi:10.3122/jabfm.2012.06.120128
26. Zajonc R. B., (1980). Feeling and thinking: Preferences need no inferences. American Psychologist, 35, 151-175.